16-88806088-G-C
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_030928.4(CDT1):āc.900G>Cā(p.Gln300His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000262 in 1,601,910 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_030928.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDT1 | NM_030928.4 | c.900G>C | p.Gln300His | missense_variant | 6/10 | ENST00000301019.9 | NP_112190.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDT1 | ENST00000301019.9 | c.900G>C | p.Gln300His | missense_variant | 6/10 | 1 | NM_030928.4 | ENSP00000301019.4 | ||
CDT1 | ENST00000569140.1 | c.168G>C | p.Gln56His | missense_variant | 2/5 | 3 | ENSP00000456926.1 | |||
CDT1 | ENST00000562747.1 | n.606G>C | non_coding_transcript_exon_variant | 5/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00150 AC: 228AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000375 AC: 86AN: 229574Hom.: 0 AF XY: 0.000271 AC XY: 34AN XY: 125564
GnomAD4 exome AF: 0.000132 AC: 192AN: 1449546Hom.: 1 Cov.: 39 AF XY: 0.000108 AC XY: 78AN XY: 720922
GnomAD4 genome AF: 0.00150 AC: 228AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.00162 AC XY: 121AN XY: 74508
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 02, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2024 | The c.900G>C (p.Q300H) alteration is located in exon 6 (coding exon 6) of the CDT1 gene. This alteration results from a G to C substitution at nucleotide position 900, causing the glutamine (Q) at amino acid position 300 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
CDT1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at